Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening
Journal of Medical Screening · 2026-12 · 33 (4) · 319-319
DOI: 10.1177/09691413261453331 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Medical Screening, online erschienen am 26.05.2026. Verfasst von Jonathan P Bestwick und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK.
- UCL Institute of Health Informatics, University College London, London, UK.
ORCID-Profile: Jonathan P Bestwick, Nicholas J Wald
Zitieren
APA
Bestwick, J. P., & Wald, N. J. (2026). Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening. Journal of Medical Screening, 33(4), 319-319. https://doi.org/10.1177/09691413261453331
Vancouver
Bestwick JP, Wald NJ. Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening. Journal of Medical Screening. 2026;33(4):319-319. doi:10.1177/09691413261453331
BibTeX
@article{Bestwick2026,
author = {Bestwick, Jonathan P and Wald, Nicholas J},
title = {Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening},
journal = {Journal of Medical Screening},
year = {2026},
volume = {33},
number = {4},
pages = {319--319},
doi = {10.1177/09691413261453331}
}
EUVIMED